EP2676663 - TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.03.2019 Database last updated on 29.10.2024 | |
Former | The patent has been granted Status updated on 20.04.2018 | ||
Former | Grant of patent is intended Status updated on 18.12.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Industry-Academic Cooperation Foundation, Chosun University 375, Seosuk-dong Dong-gu Gwangju-city 501-759 / KR | For all designated states TAHO Pharmaceuticals Ltd. 20F, No. 189, Sec. 2 Keelung Road Taipei 110 / TW | [2018/21] |
Former [2014/11] | For all designated states Industry-academic Cooperation Foundation, Chosun University 375, Seosuk-dong Dong-gu Gwangju 501-759 / KR | ||
For all designated states TAHO Pharmaceuticals Ltd. 20F, No. 189, Sec. 2 Keelung Road Taipei 110 / TW | |||
Former [2014/10] | For all designated states TAHO Pharmaceuticals Ltd. 20F, No. 189, Sec. 2 Keelung Road Taipei 110 / TW | ||
Former [2013/52] | For all designated states Industry-academic Cooperation Foundation, Chosun University 375, Seosuk-dong Dong-gu Gwangju 501-759 / KR | Inventor(s) | 01 /
CHOI, Hoo-Kyun 3-1408 Pyeonghwa Mansion 768 Hak-dong Dong-gu Gwangju 501-847 / KR | 02 /
CHUN, Myung-Kwan 501 Sewon Bldg. 1196-5 Gaepo 4-dong Gangnam-gu Seoul 135-962 / KR | [2013/52] | Representative(s) | Becker Kurig & Partner Patentanwälte mbB Bavariastraße 7 80336 München / DE | [N/P] |
Former [2018/21] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | ||
Former [2013/52] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | Application number, filing date | 12746904.7 | 17.02.2012 | [2018/21] | WO2012KR01186 | Priority number, date | KR20110014530 | 18.02.2011 Original published format: KR 20110014530 | [2013/52] | Filing language | KO | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012111996 | Date: | 23.08.2012 | Language: | KO | [2012/34] | Type: | A2 Application without search report | No.: | EP2676663 | Date: | 25.12.2013 | Language: | EN | [2013/52] | Type: | B1 Patent specification | No.: | EP2676663 | Date: | 23.05.2018 | Language: | EN | [2018/21] | Search report(s) | International search report - published on: | KR | 26.10.2012 | (Supplementary) European search report - dispatched on: | EP | 08.05.2015 | Classification | IPC: | A61K9/70, A61K47/30, A61K31/55 | [2013/52] | CPC: |
A61K31/55 (EP,KR,US);
A61K9/70 (EP,KR,US);
A61K47/14 (US);
A61K47/30 (KR);
A61K47/32 (US);
A61K9/7023 (US);
A61K9/7053 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/52] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | TRANSDERMALES ABGABESYSTEM MIT GALANTAMIN ODER SALZEN DAVON | [2013/52] | English: | TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF | [2013/52] | French: | ADMINISTRATION TRANSDERMIQUE CONTENANT DE LA GALANTAMINE OU SES SELS | [2013/52] | Entry into regional phase | 16.08.2013 | Translation filed | 16.08.2013 | National basic fee paid | 16.08.2013 | Search fee paid | 16.08.2013 | Designation fee(s) paid | 16.08.2013 | Examination fee paid | Examination procedure | 16.08.2013 | Examination requested [2013/52] | 04.12.2015 | Amendment by applicant (claims and/or description) | 19.12.2017 | Communication of intention to grant the patent | 09.04.2018 | Fee for grant paid | 09.04.2018 | Fee for publishing/printing paid | 09.04.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.12.2017 | Opposition(s) | 26.02.2019 | No opposition filed within time limit [2019/18] | Fees paid | Renewal fee | 28.02.2014 | Renewal fee patent year 03 | 03.02.2015 | Renewal fee patent year 04 | 17.02.2016 | Renewal fee patent year 05 | 16.01.2017 | Renewal fee patent year 06 | 18.01.2018 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 17.02.2012 | AL | 23.05.2018 | AT | 23.05.2018 | CY | 23.05.2018 | CZ | 23.05.2018 | DK | 23.05.2018 | EE | 23.05.2018 | ES | 23.05.2018 | FI | 23.05.2018 | HR | 23.05.2018 | IT | 23.05.2018 | LT | 23.05.2018 | LV | 23.05.2018 | MC | 23.05.2018 | MK | 23.05.2018 | NL | 23.05.2018 | PL | 23.05.2018 | RO | 23.05.2018 | RS | 23.05.2018 | SE | 23.05.2018 | SI | 23.05.2018 | SK | 23.05.2018 | SM | 23.05.2018 | TR | 23.05.2018 | BG | 23.08.2018 | NO | 23.08.2018 | GR | 24.08.2018 | IS | 23.09.2018 | PT | 24.09.2018 | GB | 17.02.2019 | IE | 17.02.2019 | LU | 17.02.2019 | MT | 17.02.2019 | [2022/31] |
Former [2021/32] | HU | 17.02.2012 | |
AL | 23.05.2018 | ||
AT | 23.05.2018 | ||
CY | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
TR | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
IS | 23.09.2018 | ||
PT | 24.09.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
MT | 17.02.2019 | ||
Former [2021/31] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CY | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
TR | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
IS | 23.09.2018 | ||
PT | 24.09.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
MT | 17.02.2019 | ||
Former [2021/26] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CY | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
TR | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
PT | 24.09.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
MT | 17.02.2019 | ||
Former [2020/29] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
TR | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
PT | 24.09.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
MT | 17.02.2019 | ||
Former [2020/16] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
TR | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
Former [2020/11] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
GB | 17.02.2019 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
Former [2020/09] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
IE | 17.02.2019 | ||
LU | 17.02.2019 | ||
Former [2019/51] | AL | 23.05.2018 | |
AT | 23.05.2018 | ||
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
LU | 17.02.2019 | ||
Former [2019/47] | AT | 23.05.2018 | |
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
LU | 17.02.2019 | ||
Former [2019/45] | AT | 23.05.2018 | |
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
MC | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2019/26] | AT | 23.05.2018 | |
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SI | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2019/11] | AT | 23.05.2018 | |
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
IT | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SK | 23.05.2018 | ||
SM | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2019/10] | AT | 23.05.2018 | |
CZ | 23.05.2018 | ||
DK | 23.05.2018 | ||
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
PL | 23.05.2018 | ||
RO | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
SK | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2019/09] | DK | 23.05.2018 | |
EE | 23.05.2018 | ||
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2019/08] | DK | 23.05.2018 | |
ES | 23.05.2018 | ||
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2018/52] | ES | 23.05.2018 | |
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
NL | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
GR | 24.08.2018 | ||
Former [2018/51] | ES | 23.05.2018 | |
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
LV | 23.05.2018 | ||
RS | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
Former [2018/50] | ES | 23.05.2018 | |
FI | 23.05.2018 | ||
HR | 23.05.2018 | ||
LT | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
Former [2018/49] | ES | 23.05.2018 | |
FI | 23.05.2018 | ||
LT | 23.05.2018 | ||
SE | 23.05.2018 | ||
BG | 23.08.2018 | ||
NO | 23.08.2018 | ||
Former [2018/47] | ES | 23.05.2018 | |
FI | 23.05.2018 | ||
LT | 23.05.2018 | ||
NO | 23.08.2018 | Documents cited: | Search | [XI]US2005074487 (HSU TSUNG-MIN [US], et al) [X] 1-4,6,8,9 * paragraphs [0437] - [0444]; example 23; tables 78-81 * * claim - * * paragraphs [0135] - [0137] - [0238] , [0257] - [0267] *[I] 5,7,10,11; | [XI]US2006257462 (JANSEN ROLF R [US], et al) [X] 1-5,10,11 * figure -; example -; claim - * * paragraphs [0033] - [0038] - [0057] , [0058] , [0063] - [0068] * [I] 6-9; | [XI]WO2007035941 (ALZA CORP [US], et al) [X] 1-6,8-11 * paragraphs [0028] - [0031] - [0054] - [0065] * * example -; claim - * [I] 7 | International search | [A]US5089267 (HILLE THOMAS DR [DE], et al); | [A]US5700480 (HILLE THOMAS [DE], et al); | [A]US5932238 (OPITZ K [DE]); | [A]US6558696 (HILLE THOMAS [DE], et al); | [A]WO2007064407 (NOVARTIS AG [CH], et al) | by applicant | US5700480 | US2007104771 | - COYLE, J.; KERSHAW, P., "Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimers disease", BIOL. PSYCHIATRY, (2001), vol. 49, doi:doi:10.1016/S0006-3223(00)01101-X, pages 289 - 299, XP001098881 DOI: http://dx.doi.org/10.1016/S0006-3223(00)01101-X | - ZAROTSKY, V.; SRAMEK, J.J.; CUTLER, N.R., "Galantamine hydrobromide: an agent for Alzheimer's disease", AM. J. HEALTH-SYST. PHARM, (2001), vol. 60, pages 446 - 452 | - SCOTT, L.J.; GOA, K.L., "Galantamine: a review of its use in Alzheimer's disease", DRUGS, (2000), vol. 60, doi:doi:10.2165/00003495-200060050-00008, pages 1095 - 1122, XP009056233 DOI: http://dx.doi.org/10.2165/00003495-200060050-00008 | - COREY-BLOOM, J, "Galantamine: a review of its use in Alzheimer's disease and vascular dementia", INT. J. CLIN. PRACT, (2003), vol. 57, pages 219 - 223, XP008050022 | - THOMAS, B.J.; FINNIN, F.C., "The transdermal revolution", DRUG DISCOV, (2004), vol. 9, pages 697 - 703 | - WALTERS, K.A.; WALKER, M.; OLEJNIK, O., "Non-ionic surfactant effects on hairless mouse skin permeability characteristics", J. PHARM. PHARMACOL, (1987), vol. 40, pages 525 - 529 | - WILLIAMS, A.C.; BARRY, B.W., "Permeation enhancers", ADV. DRUG DELIVER. REV, (2004), vol. 56, pages 603 - 618 | - ANG, C.; FEN, H.E.; SUB, H.E., "Pharmacokinetics of galantamine Hbr in plasma and brain of mice", CHIN. J. PHARM, (2006), vol. 37, pages 55 - 61 | - CHOI, H-K.; ANGELLO, J., "The Mathematical analysis and optimization of a flow through diffusion cell system", PHARM. RES, (1994), vol. 11, pages 595 - 599 | - SUBEDI, R.K.; JANG, J.H.; KIM, JAE-II; PARK, Y.J; CHOI, H.-K., "Formulation and evaluation of transdermal patch containing sibutramine", J. KOR. PHARM. SCI, (2010), vol. 40, pages 33 - 38 | - KIM, J.H.; CHO Y.-J.; CHOI, H.-K., "Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin", INT. J. PHARM, (2000), vol. 196, doi:doi:10.1016/S0378-5173(99)00449-4, pages 105 - 113, XP000998581 DOI: http://dx.doi.org/10.1016/S0378-5173(99)00449-4 | - MORIMOTO, Y.; KOKUBO, T.; SUGIBAYASHI, K., "Diffusion of drug in acrylic type pressure sensitive adhesive matrix. II. Influence of interaction", J. CONTROL. RELEASE, (1992), vol. 18, doi:doi:10.1016/0168-3659(92)90180-Y, pages 113 - 121, XP000247008 DOI: http://dx.doi.org/10.1016/0168-3659(92)90180-Y | - SUBEDI, R.K.; JANG, J.H.; KIM, JAE-II; PARK, Y.J.; CHOI, H.-K., "Formulation and evaluation of transdermal patch containing sibutramine", J. KOR. PHARM. SCI, (2010), vol. 40, pages 33 - 38 | - FURUISHI, T.; LO, T.; FUKAMI, T.; SUZUKI, T.; TOMONO, K., "Formulation and in vitro evaluation of pentazocine transdermal delivery system", BIOL. PHARM. BULL, (2008), vol. 31, pages 1439 - 1443 | - WOKOVICH, A.M.; PRODDUTURI, S.; DOUB, W.H.; HUSSAIN, A.S.; BUHSE, L.F., "Transdermal delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute", EUR. J. PHARM. BIOPHARM, (2006), vol. 64, doi:doi:10.1016/j.ejpb.2006.03.009, pages 1 - 8, XP027997908 DOI: http://dx.doi.org/10.1016/j.ejpb.2006.03.009 |